First Half of 2020 total sales down 47%; U.S. sales down 19%
Second Quarter total sales down 72%; U.S. sales down 47%
Sufficient liquidity to manage the business through the third quarter of 2021
News
Mauna Kea Technologies reports second quarter and first half of 2020 sales
20 July 2020
Latest News
Mauna Kea Technologies Announces Publication of a Landmark Systematic Review and Meta-Analysis Reinforcing the Diagnostic Accuracy and Clinical Impact of Cellvizio in Upper Gastrointestinal Cancer
Mauna Kea Technologies Announces Two New Peer-Reviewed Clinical Studies Confirming the Clinical Value of Cellvizio® and Its Combination with AI for the Diagnosis of Pancreatic Cysts
No results found.